{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:10:00Z","timestamp":1770509400102,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s40263-013-0050-5","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T15:08:56Z","timestamp":1362496136000},"page":"233-237","source":"Crossref","is-referenced-by-count":20,"title":["Feasibility of Following up Gamma-Hydroxybutyric Acid Concentrations in Sodium Oxybate (Xyrem\u00ae)-Treated Narcoleptic Patients Using Dried Blood Spot Sampling at Home"],"prefix":"10.1007","volume":"27","author":[{"given":"Ann-Sofie M. E.","family":"Ingels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien B.","family":"Hertegonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willy E.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"issue":"36","key":"50_CR1","first-page":"599","volume":"105","author":"H Andresen","year":"2008","unstructured":"Andresen H, Stimpfl T, Sprys N, et al. Liquid ecstasy: a significant drug problem. Dtsch Arztebl Int. 2008;105(36):599\u2013603.","journal-title":"Dtsch Arztebl Int"},{"issue":"1\u20133","key":"50_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.forsciint.2010.03.035","volume":"200","author":"H Andresen","year":"2010","unstructured":"Andresen H, Sprys N, Schmoldt A, et al. Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations. Forensic Sci Int. 2010;200(1\u20133):93\u20139.","journal-title":"Forensic Sci Int"},{"issue":"1\u20132","key":"50_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.04.012","volume":"104","author":"LP Carter","year":"2009","unstructured":"Carter LP, Pardi D, Gorsline J, et al. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug Alcohol Depend. 2009;104(1\u20132):1\u201310.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"50_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002018-200427050-00002","volume":"27","author":"DE Fuller","year":"2004","unstructured":"Fuller DE, Hornfeldt CS, Kelloway JS, et al. The Xyrem\u00ae risk management program. Drug Saf. 2004;27(5):293\u2013306.","journal-title":"Drug Saf"},{"issue":"12","key":"50_CR5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","volume":"20","author":"D Pardi","year":"2006","unstructured":"Pardi D, Black J. \u03b3-Hydroxybutyrate\/sodium oxybate neurobiology, and impact on sleep and wakefulness. CNS Drugs. 2006;20(12):993\u20131018.","journal-title":"CNS Drugs"},{"issue":"4","key":"50_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00023210-200721040-00007","volume":"21","author":"DM Robinson","year":"2007","unstructured":"Robinson DM, Keating GM. Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs. 2007;21(4):337\u201354.","journal-title":"CNS Drugs"},{"issue":"20","key":"50_CR7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.4155\/bio.11.204","volume":"3","author":"ASME Ingels","year":"2011","unstructured":"Ingels ASME, De Paepe P, Anseeuw K, et al. Dried blood spot punches for the confirmation of suspected \u03b3-hydroxybutyric acid intoxications: validation of an optimized GC\u2013MS procedure. Bioanalysis. 2011;3(20):2271\u201381.","journal-title":"Bioanalysis"},{"issue":"1","key":"50_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","volume":"24","author":"W Li","year":"2010","unstructured":"Li W, Tse F. Dried blood spot sampling in combination with LC\u2013MS\/MS for quantitative analysis of small molecules. Biomed Chromatogr. 2010;24(1):49\u201365.","journal-title":"Biomed Chromatogr"},{"key":"50_CR9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/bmc.1580","volume":"25","author":"T Boer De","year":"2011","unstructured":"De Boer T, Wieling J, Meulman E, et al. Application of dried blood spot sampling combined with LC\u2013MS\/MS for genotyping and phenotyping of CYP450 enzymes in healthy volunteers. Biomed Chromatogr. 2011;25:1112\u201323.","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"50_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","volume":"31","author":"PM Edelbroek","year":"2009","unstructured":"Edelbroek PM, Van Der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit. 2009;31(3):327\u201336.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"50_CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10408444.2011.650790","volume":"42","author":"CP Stove","year":"2012","unstructured":"Stove CP, Ingels ASME, De Kesel PMM, et al. Dried blood spots in toxicology: from the cradle to the grave? Crit Rev Toxicol. 2012;42(3):230\u201343.","journal-title":"Crit Rev Toxicol"},{"key":"50_CR12","doi-asserted-by":"crossref","first-page":"201918","DOI":"10.1155\/2010\/201918","volume":"2010","author":"AB Leichtle","year":"2010","unstructured":"Leichtle AB, Ceglarek U, Witzigmann H, et al. Potential of dried blood self-sampling for cyclosporine C2 monitoring in transplant outpatients. J Transplant. 2010;2010:201918.","journal-title":"J Transplant"},{"issue":"10","key":"50_CR13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1515\/CCLM.2009.274","volume":"47","author":"MR Fokkema","year":"2009","unstructured":"Fokkema MR, Bakker AJ, de Boer F, et al. HbA1c measurements from dried blood spots: validation and patient satisfaction. Clin Chem Lab Med. 2009;47(10):1259\u201364.","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl. 1","key":"50_CR14","doi-asserted-by":"crossref","first-page":"i131","DOI":"10.1093\/geronb\/gbn022","volume":"64","author":"SR Williams","year":"2009","unstructured":"Williams SR, McDade TW. The use of dried blood spot sampling in the national social life, health and aging project. J Gerontol B Psycol Sci Soc Sci. 2009;64(Suppl. 1):i131\u20136.","journal-title":"J Gerontol B Psycol Sci Soc Sci"},{"issue":"5","key":"50_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/21.5.507","volume":"21","author":"MB Scharf","year":"1998","unstructured":"Scharf MB, Lai AA, Branigan B, et al. Pharmacokinetics of gamma-hydroxybutyrate (GHB) in narcoleptic patients. Sleep. 1998;21(5):507\u201314.","journal-title":"Sleep"},{"key":"50_CR16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1196\/annals.1369.065","volume":"1074","author":"S Abanades","year":"2006","unstructured":"Abanades S, Farre M, Segura M, et al. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann N Y Acad Sci. 2006;1074:559\u201376.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"50_CR17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.sleep.2009.01.005","volume":"10","author":"DL Zvosec","year":"2009","unstructured":"Zvosec DL, Smith SW, Hall BJ. Three deaths associated with the use of Xyrem\u00ae. Sleep Med. 2009;10(4):490\u20133.","journal-title":"Sleep Med"},{"issue":"8","key":"50_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jat\/28.8.625","volume":"28","author":"R Brenneisen","year":"2004","unstructured":"Brenneisen R, Elsohly MA, Murphy TP, et al. Pharmacokinetics and excretion of gamma-hydroxybutyric acid (GHB) in healthy subjects. J Anal Toxicol. 2004;28(8):625\u201330.","journal-title":"J Anal Toxicol"},{"issue":"4","key":"50_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0735-6757(91)90050-T","volume":"9","author":"JE Dyer","year":"1991","unstructured":"Dyer JE. gamma-Hydroxybutyrate: a health-food product producing coma and seizure-like activity. Am J Emerg Med. 1991;9(4):321\u20134.","journal-title":"Am J Emerg Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-013-0050-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0050-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:16Z","timestamp":1559504476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-013-0050-5"}},"subtitle":["An Exploratory Study"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s40263-013-0050-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}